ADAR and cancer: ADAR1 overexpression and ADAR1 editing have been reported to be positively correlated with promoting cancer cell survival and poor cancer prognosis in several types of cancers, including oral squamous cell carcinoma18, triple negative breast cancer19, prostate cancer20, and non-small cell lung cancer21.